Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study by Devonshire, Virginia, MD, Havrdova, Eva, MD, Radue, Ernst Wilhelm, Prof, O'Connor, Paul, MD, Zhang-Auberson, Lixin, MD, Agoropoulou, Catherine, PhD, Häring, Dieter Adrian, PhD, Francis, Gordon, MD, Kappos, Ludwig, Prof

Get full text